+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Myopia & Presbyopia Treatment Market by Treatment, Indication - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 196 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5012905
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Myopia & Presbyopia Treatment Market grew from USD 19.47 billion in 2023 to USD 20.90 billion in 2024. It is expected to continue growing at a CAGR of 7.84%, reaching USD 33.04 billion by 2030.

The market for myopia and presbyopia treatment primarily encompasses a range of products and services designed to correct vision impairment caused by these refractive errors. Myopia, commonly known as nearsightedness, and presbyopia, the age-related difficulty in seeing nearby objects, are prevalent conditions that necessitate effective interventions. These include spectacles, contact lenses, surgical options such as LASIK, and emerging pharmaceutical treatments. The end-users are predominantly individuals over 40 (for presbyopia) and younger individuals (for myopia), alongside healthcare providers and optical retailers who offer these solutions. Market growth is driven by increasing incidences of these conditions due to lifestyle changes, including rising screen time and aging populations, while technological advancements like improved lens materials and surgical techniques present additional impetus.

Key growth factors include increased awareness about eye health and corrective measures, a growing geriatric population prone to presbyopia, and innovation in medical procedures providing better outcomes. Potential opportunities arise in expanding minimally invasive surgical options, developing advanced optical devices, and personalizing treatment approaches through data-driven insights. To capitalize on these opportunities, businesses should invest in R&D for more comfortable, efficient, and affordable solutions and strengthen collaborations with healthcare systems to enhance access.

However, market expansion faces challenges such as the high cost of advanced treatments, limited accessibility in developing regions, and regulatory hurdles in the approval of new technologies. Additionally, competition from alternative vision correction methods like ortho-k lenses may impact market dynamics.

Future innovations might involve the integration of AI in diagnosis and customized treatment planning, biocompatible materials for contact lenses, and further research into pharmacological solutions. The market is poised for steady growth owing to sustained demand and continued technological progression, but industry players must navigate competitive landscapes and regulatory environments carefully to succeed. Engaging in strategic partnerships and continuous innovation are crucial for maintaining a competitive edge.

Understanding Market Dynamics in the Myopia & Presbyopia Treatment Market

The Myopia & Presbyopia Treatment Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Increasing Prevalence of Vision Impairment
    • Rising Geriatric Population
    • Minimally Invasive Alternative for Presbyopia Correction
  • Market Restraints
    • Lack of Early Diagnosis and Product Recalls
  • Market Opportunities
    • Increasing Market Amalgamation Activity
    • Emerging Developments with Introduction of Advanced Lenses such as Implantable Contact Lenses
  • Market Challenges
    • High Cost Associated with the Treatment

Exploring Porter’s Five Forces for the Myopia & Presbyopia Treatment Market

Porter’s Five Forces framework further strengthens the insights of the Myopia & Presbyopia Treatment Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Myopia & Presbyopia Treatment Market

External macro-environmental factors deeply influence the performance of the Myopia & Presbyopia Treatment Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Myopia & Presbyopia Treatment Market

The Myopia & Presbyopia Treatment Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Myopia & Presbyopia Treatment Market

The Myopia & Presbyopia Treatment Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Myopia & Presbyopia Treatment Market

The Myopia & Presbyopia Treatment Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Myopia & Presbyopia Treatment Market, highlighting leading vendors and their innovative profiles. These include ABB Optical Group, AbbVie Inc., Accu-Lens Inc., Alcon Vision LLC, Arctic Vision, Bausch & Lomb Incorporated by Bausch Health Companies Inc., Carl Zeiss AG, CooperVision, Inc., Essilor Group, Euclid Systems Corporation, Eyenovia, Inc., Haag-Streit Group, Johnson & Johnson Vision, Menicon Co., Ltd., Nidek Co. Ltd., Topcon Corporation, Tylock-George Eye Care & Laser Center, and Ziemer Ophthalmic Systems AG.

Market Segmentation & Coverage

This research report categorizes the Myopia & Presbyopia Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Treatment
    • Contact Lenses
    • Medication
    • Prescription Lenses
    • Surgery
  • Indication
    • Myopia
    • Presbyopia
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing Prevalence of Vision Impairment
5.1.1.2. Rising Geriatric Population
5.1.1.3. Minimally Invasive Alternative for Presbyopia Correction
5.1.2. Restraints
5.1.2.1. Lack of Early Diagnosis and Product Recalls
5.1.3. Opportunities
5.1.3.1. Increasing Market Amalgamation Activity
5.1.3.2. Emerging Developments with Introduction of Advanced Lenses such as Implantable Contact Lenses
5.1.4. Challenges
5.1.4.1. High Cost Associated with the Treatment
5.2. Market Segmentation Analysis
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Myopia & Presbyopia Treatment Market, by Treatment
6.1. Introduction
6.2. Contact Lenses
6.3. Medication
6.4. Prescription Lenses
6.5. Surgery
7. Myopia & Presbyopia Treatment Market, by Indication
7.1. Introduction
7.2. Myopia
7.3. Presbyopia
8. Americas Myopia & Presbyopia Treatment Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Myopia & Presbyopia Treatment Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
9.13. Vietnam
10. Europe, Middle East & Africa Myopia & Presbyopia Treatment Market
10.1. Introduction
10.2. Denmark
10.3. Egypt
10.4. Finland
10.5. France
10.6. Germany
10.7. Israel
10.8. Italy
10.9. Netherlands
10.10. Nigeria
10.11. Norway
10.12. Poland
10.13. Qatar
10.14. Russia
10.15. Saudi Arabia
10.16. South Africa
10.17. Spain
10.18. Sweden
10.19. Switzerland
10.20. Turkey
10.21. United Arab Emirates
10.22. United Kingdom
11. Competitive Landscape
11.1. Market Share Analysis, 2023
11.2. FPNV Positioning Matrix, 2023
11.3. Competitive Scenario Analysis
11.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. MYOPIA & PRESBYOPIA TREATMENT MARKET RESEARCH PROCESS
FIGURE 2. MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2030 (%)
FIGURE 7. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 9. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. AMERICAS MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 11. AMERICAS MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. UNITED STATES MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 13. UNITED STATES MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. ASIA-PACIFIC MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. ASIA-PACIFIC MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. EUROPE, MIDDLE EAST & AFRICA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. MYOPIA & PRESBYOPIA TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 19. MYOPIA & PRESBYOPIA TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. MYOPIA & PRESBYOPIA TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. MYOPIA & PRESBYOPIA TREATMENT MARKET DYNAMICS
TABLE 7. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY CONTACT LENSES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY MEDICATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY PRESCRIPTION LENSES, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY MYOPIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY PRESBYOPIA, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. AMERICAS MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 16. AMERICAS MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 17. AMERICAS MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 18. ARGENTINA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 19. ARGENTINA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 20. BRAZIL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 21. BRAZIL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 22. CANADA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 23. CANADA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 24. MEXICO MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 25. MEXICO MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 26. UNITED STATES MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 27. UNITED STATES MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 28. UNITED STATES MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 29. ASIA-PACIFIC MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 30. ASIA-PACIFIC MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 31. ASIA-PACIFIC MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 32. AUSTRALIA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 33. AUSTRALIA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 34. CHINA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 35. CHINA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 36. INDIA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 37. INDIA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 38. INDONESIA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 39. INDONESIA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 40. JAPAN MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 41. JAPAN MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 42. MALAYSIA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 43. MALAYSIA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 44. PHILIPPINES MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 45. PHILIPPINES MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 46. SINGAPORE MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 47. SINGAPORE MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 48. SOUTH KOREA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 49. SOUTH KOREA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 50. TAIWAN MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 51. TAIWAN MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 52. THAILAND MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 53. THAILAND MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 54. VIETNAM MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 55. VIETNAM MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 56. EUROPE, MIDDLE EAST & AFRICA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 57. EUROPE, MIDDLE EAST & AFRICA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 58. EUROPE, MIDDLE EAST & AFRICA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 59. DENMARK MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 60. DENMARK MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 61. EGYPT MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 62. EGYPT MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 63. FINLAND MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 64. FINLAND MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 65. FRANCE MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 66. FRANCE MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 67. GERMANY MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 68. GERMANY MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 69. ISRAEL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 70. ISRAEL MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 71. ITALY MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 72. ITALY MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 73. NETHERLANDS MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 74. NETHERLANDS MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 75. NIGERIA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 76. NIGERIA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 77. NORWAY MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 78. NORWAY MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 79. POLAND MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 80. POLAND MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 81. QATAR MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 82. QATAR MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 83. RUSSIA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 84. RUSSIA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 85. SAUDI ARABIA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 86. SAUDI ARABIA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 87. SOUTH AFRICA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 88. SOUTH AFRICA MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 89. SPAIN MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 90. SPAIN MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 91. SWEDEN MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 92. SWEDEN MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 93. SWITZERLAND MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 94. SWITZERLAND MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 95. TURKEY MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 96. TURKEY MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 97. UNITED ARAB EMIRATES MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 98. UNITED ARAB EMIRATES MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 99. UNITED KINGDOM MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY TREATMENT, 2018-2030 (USD MILLION)
TABLE 100. UNITED KINGDOM MYOPIA & PRESBYOPIA TREATMENT MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
TABLE 101. MYOPIA & PRESBYOPIA TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
TABLE 102. MYOPIA & PRESBYOPIA TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Myopia & Presbyopia Treatment Market, which are profiled in this report, include:
  • ABB Optical Group
  • AbbVie Inc.
  • Accu-Lens Inc.
  • Alcon Vision LLC
  • Arctic Vision
  • Bausch & Lomb Incorporated by Bausch Health Companies Inc.
  • Carl Zeiss AG
  • CooperVision, Inc.
  • Essilor Group
  • Euclid Systems Corporation
  • Eyenovia, Inc.
  • Haag-Streit Group
  • Johnson & Johnson Vision
  • Menicon Co., Ltd.
  • Nidek Co. Ltd.
  • Topcon Corporation
  • Tylock-George Eye Care & Laser Center
  • Ziemer Ophthalmic Systems AG

Methodology

Loading
LOADING...

Table Information